Precision for Medicine acquires Redwood Outcomes, a Canadian HEOR firm
Acquisition adds more expertise in epidemiology and patient outcomes analysis
Precision for Value, a unit of New York-based Precision for Medicine, is adding Redwood Outcomes, based in Vancouver, BC to its stable. Earlier this year, the company had acquired Precision Health Economics (PHE); Redwood will be managed as a subsidiary of PHE, says the company.
Precision for Medicine itself comes together as a group of consulting organization and service providers, mostly for pharma clients: Hobart Group Holdings, Core Access Group, and PHE. The company has 10 offices (now 14, presuming the Vancouver office will remain open), and operates both in the US and in Europe. It specializes in market access issues, payer and managed markets research and promotion, health outcomes and contract administration.
Machine Health in Pharmaceutical Production
December 2nd 2024Predictive maintenance in pharmaceutical production can help reduce downtime and increase efficiency. Grundfos Machine Health (GMH) uses artificial intelligence (AI)-driven wireless sensors to monitor motor health in real-time, identifying potential issues. This approach not only reduces maintenance costs but also ensures compliance with industry standards.
